#17,619
In 2019, just prior to the COVID lockdown, the United States reported 1274 measles cases (see COCA Call: Most Measles Cases In 25 Years), raising concerns that this scourge - considered eliminated in the U.S. since 2000 - was making a comeback.
The following year, when the world went into lockdown for COVID, the rate of measles - along with influenza, RSV, and many other communicable diseases - dropped precipitously.
But last year, the number of measles here in the United States began to creep up again (n=121), and while only 19 cases have been reported (so far) in 2023, the CDC is desirous of keeping those numbers low. Later today they will hold a COCA call for clinicians on recognizing, treating, and preventing measles.
These presentations are often technical, and are of greatest interest to clinicians and healthcare providers, but also may be of interest to the general public.
As always, If you are unable to attend the live presentation, these (and past) webinars are archived and available for later viewing at this LINK.
We Must Maintain Measles Elimination in the United States: Measles Clinical Presentation, Diagnosis, and Prevention
= Free Continuing Education
Overview
The United States has maintained the elimination of measles, defined as the absence of continuous disease transmission for ≥12 months, since 2000. However, measles cases can occur when people travel to and from the United States, especially when travelers are unvaccinated or under-vaccinated against measles. Maintaining measles elimination in the United States requires continued investment in the measles vaccination program which was instrumental to achieving elimination. Health care providers and public health authorities need to remain vigilant to rapidly recognize measles and take steps to mitigate spread within communities for continued measles elimination. The Centers for Disease Control and Prevention (CDC) urges all healthcare providers to ensure their patients are up to date on the measles, mumps, and rubella (MMR vaccine). Healthcare providers should consider measles as a diagnosis in anyone with fever (≥101°F or 38.3°C) and a generalized maculopapular rash with cough, coryza, or conjunctivitis who has recently been abroad, especially in countries with ongoing outbreaks.
During this COCA Call, presenters will discuss the history of measles in the United States, review clinical presentation and diagnosis of measles infection, review how to report suspected cases to public health agencies, and outline recommendations for measles vaccination in the United States.
Presenters
Adria Mathis, MSPH
Epidemiologist
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Dan Filardo, MD
Medical Officer
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Stephen Crooke, PhD
Lead Research Microbiologist
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Call Details
When:
Thursday, August 17, 2023,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1603132944
Webinar ID: 160 313 2944
Passcode: 532989
Telephone:+1
646 828 7666 US (New York)
One-tap mobile:
+16692545252,,1603132944#,,,,*532989# US (San Jose)
+16468287666,,1603132944#,,,,*532989# US (New York)
International numbers
